Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Resultaten hiv-behandeling na de introductie van integraseremmers in Britse richtlijnen
jan 2021 | HIV, Virale infecties